# Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 Years with Cystic Fibrosis and at Least One F508del Allele Receiving Elexacaftor/Tezacaftor/Ivacaftor

*PRI Rank #19 · Topics and Trends in Most Cited Pediatric health and respiratory diseases Papers, Class of 2026*

*Canonical URL: https://pri.pepkio.com/top-papers/pediatric-health-and-respiratory-diseases/2026/rank-19*

| Field | Value |
| --- | --- |
| Rank | #19 |
| 18m citations | 18 |
| Journal | The Journal of Pediatrics |
| Year | 2024 |
| DOI | 10.1016/j.jpeds.2024.114176 |
| Corresponding authors | Vito Terlizzi |
| Institution | Meyer Children's Hospital IRCCS, Italy |

**Ranking page:** [Topics and Trends in Most Cited Pediatric health and respiratory diseases Papers, Class of 2026](https://pri.pepkio.com/top-papers/pediatric-health-and-respiratory-diseases/2026)

**Paper link:** [10.1016/j.jpeds.2024.114176](https://doi.org/10.1016/j.jpeds.2024.114176)

## Topics

Elexacaftor/tezacaftor/ivacaftor · F508del mutation · CFTR modulator therapy · Pediatric cystic fibrosis cohort · Multicenter cohort study · Adverse events · CFTR modulator safety monitoring

## Cite this ranking

```
Pepkio Research Index (PRI). Topics and Trends in Most Cited Pediatric health and respiratory diseases Papers, Class of 2026. https://pri.pepkio.com/top-papers/pediatric-health-and-respiratory-diseases/2026. Accessed 2026-07-14.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
```